Hookipa Pharma Inc Reports Results For The Quarter Ended In March: Earnings Summary

Hookipa Pharma

11/05/2023 14:32

* HOOKIPA Pharma Inc  HOOK.OQ  reported a quarterly adjusted
loss
of 27 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 23 cents per share.
    * Revenue rose 119.8% to $3.18 million from a year ago;
analysts
expected $4.39 million. 
    * HOOKIPA Pharma Inc's reported EPS for the quarter was a
loss
of 27 cents​.
    * The mean earnings estimate of analysts had risen by
about 20.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * HOOKIPA Pharma Inc shares had risen by 152.7% this
quarter and
gained 129.6% so far this year.
    * The company reported a quarterly loss of $19.68 million.
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $3.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.23          -0.27          Missed
 Dec. 31 2022      -0.21          -0.17          Beat
 Sep. 30 2022      -0.28          -0.25          Beat
 Jun. 30 2022      -0.36          -0.23          Beat